News Announcement

Aurobindo Pharma: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Sub: Analyst / Investor call
Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we inform you that an analyst / investor call on the Audited Financial Results of the Company for the fourth quarter and year ended 31st March 2019 is scheduled on 29th May 2019 at 8:30 AM.
Please find attached the dial-in details of the call.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.